Targeting the endocannabinoid system in the amygdala kindling model of temporal lobe epilepsy in mice

Epilepsia

Volumn 52, Issue 7, 2011, Pages

  Wendt, Hannes ^a   Soerensen, Jonna ^a   Wotjak, Carsten T ^b   Potschka, Heidrun ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Amygdala kindling; CB1 receptor; Endocannabinoid; FAAH inhibitor; Temporal lobe epilepsy

Indexed keywords

CANNABINOID 1 RECEPTOR AGONIST; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; ENDOCANNABINOID; FATTY ACID;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CHRONIC DISEASE; CONTROLLED STUDY; DEPENDENT PERSONALITY DISORDER; ENZYMATIC DEGRADATION; MOUSE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SEIZURE THRESHOLD; TEMPORAL LOBE EPILEPSY;

AMIDOHYDROLASES; AMYGDALA; ANIMALS; BENZAMIDES; BENZOXAZINES; CARBAMATES; DISEASE MODELS, ANIMAL; EPILEPSY, TEMPORAL LOBE; KINDLING, NEUROLOGIC; MALE; MICE; MODELS, NEUROLOGICAL; MORPHOLINES; NAPHTHALENES; RECEPTOR, CANNABINOID, CB1; SEIZURES;

EID: 79959941041     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2011.03079.x     Document Type: Article

References (10)

1. Katona I, Freund TF,. (2008) Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med 14: 923-930.
2. Lutz B,. (2004) On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochem Pharmacol 68: 1691-1698. (Pubitemid 39278491)
3. Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, Gutierrez SO, van der Stelt M, Lopez-Rodriguez ML, Casanova E, Schutz G, Zieglgansberger W, Di Marzo V, Behl C, Lutz B,. (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302: 84-88. (Pubitemid 37210691)
4. Naderi N, Aziz Ahari F, Shafaghi B, Najarkolaei AH, Motamedi F,. (2008) Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice. J Neural Transm 115: 1501-1511.
5. Palomaki VA, Lehtonen M, Savinainen JR, Laitinen JT,. (2007) Visualization of 2-arachidonoylglycerol accumulation and cannabinoid CB1 receptor activity in rat brain cryosections by functional autoradiography. J Neurochem 101: 972-981. (Pubitemid 46683863)
6. Parent JM, Murphy GG,. (2008) Mechanisms and functional significance of aberrant seizure-induced hippocampal neurogenesis. Epilepsia 49 (Suppl. 5): 19-25. (Pubitemid 351782997)
7. Pekcec A, Muhlenhoff M, Gerardy-Schahn R, Potschka H,. (2007) Impact of the PSA-NCAM system on pathophysiology in a chronic rodent model of temporal lobe epilepsy. Neurobiol Dis 27: 54-66. (Pubitemid 46921474)
8. Pitkanen A, Lukasiuk K,. (2009) Molecular and cellular basis of epileptogenesis in symptomatic epilepsy. Epilepsy Behav 14 (Suppl. 1): 16-25.
9. Wallace MJ, Martin BR, DeLorenzo RJ,. (2002) Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur J Pharmacol 452: 295-301. (Pubitemid 35279432)
10. Wallace MJ, Blair RE, Falenski KW, Martin BR, DeLorenzo RJ,. (2003) The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J Pharmacol Exp Ther 307: 129-137. (Pubitemid 37151898)